Skip to main content
Log in

Technology transfer at Harvard University

  • Published:
Bioethics Quarterly Aims and scope Submit manuscript

Abstract

This memorandum was prepared by Daniel Steiner, General Counsel to Harvard University on behalf of the President's Office and distributed to the faculty in October, 1980. It reviews recent Harvard policy with regard to patents and technology transfer. Spurred by recombinant DNA research, at Harvard and elsewhere, benefits and pitfalls of the University's participation as a minor shareholder in a company engaged in research and development are identified. The author notes that “The memorandum has benefited from numerous discussions with members of the faculty and administration and in particular from the comments of President (Derek) Bok and Dean (Henry) Rosovsky.”

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steiner, D. Technology transfer at Harvard University. Bioethics Quarterly 2, 203–211 (1980). https://doi.org/10.1007/BF00917111

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917111

Keywords

Navigation